I can't see anything in that announcement referring to a 45 day timeframe, just an expectation of Q2 CY2021.
I just had a quick look and saw a more recent announcement referring to the OTC timeframe, but they just repeated the Q2 guideline.
Are you sure mentioned any guidance about a date more specific or earlier than the end of Q2 CY2021? You may have made an error somewhere.